EquityFlow
›
Companies
› Zelluna Immunotherapy
Zelluna Immunotherapy
Biotech
· Oslo, NO ·
zelluna.com
Develops TCR-guided NK cell therapies for solid tumours
Funding history
Date
Round
Amount
Aug 2022
Funding round
Oslo biopharma Zelluna Immunotherapy received an undisclosed investment from Takeda Ventures to advance its cancer cell therapy platform.
—
Investors
Takeda Ventures
Similar companies in Biotech
Imperagen
Haga Bioscience
Pixelgen Technologies
Gallant
Chai Discovery
SNIPR Biome
Cellbox Labs
Scope Biosciences
GenLumina
Actithera
NUCLIDIUM
Anocca
Explore funding flow on EquityFlow →